QuickView for MAPK1;jsessionid=CEE42355B31D8C288D6C5C69ABD395FA;jsessionid=4B22FC5C2562272EBE0080E4E592ADE2;jsessionid=01433D7C5D5D8779CE4219AB8F3BCD0A;jsessionid=4E579CE59B7A30F7E5CCE914D39175A4;jsessionid=E6209C08827F431930D1E0C800E1F6E2;jsessionid=FC770EBC40730BF9DA9112AE2AD2EE82 (gene)

1. Low entropic cost of binding confers high selectivity on an allosteric ERK2 inhibitor.
2. Targeting MAPK in Cancer 2.0.
3. MAPK-Activated Protein Kinases: Servant or Partner?
4. Evolution of mitogen-activated protein kinase family and their immune function in Apostichopus japon…
5. Proteome-wide screening for mitogen-activated protein kinase docking motifs and interactors.

There were no clinical trials for MAPK1;jsessionid=CEE42355B31D8C288D6C5C69ABD395FA;jsessionid=4B22FC5C2562272EBE0080E4E592ADE2;jsessionid=01433D7C5D5D8779CE4219AB8F3BCD0A;jsessionid=4E579CE59B7A30F7E5CCE914D39175A4;jsessionid=E6209C08827F431930D1E0C800E1F6E2;jsessionid=FC770EBC40730BF9DA9112AE2AD2EE82